MCLEAN, VA / / December 10, 2024 / Dr. Amir Bajoghli and his colleagues have recently published an insightful case study in BMJ Journals, titled ' Aquagenic Urticaria in an Adolescent: Differential ...
South Korean biopharmaceutical firm Celltrion said Monday that it has received approval from Health Canada for Omlyclo, its omalizumab biosimilar referencing Xolair, designed to treat allergic asthma ...